Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › PathSensors Gets Expanded License to MIT Pathogen Detection Technology

PathSensors Gets Expanded License to MIT Pathogen Detection Technology

Jul 09, 2020
|
staff reporter

NEW YORK — PathSensors said on Thursday that it has signed an agreement expanding its exclusive license to a Massachusetts Institute of Technology-developed pathogen detection technology to include clinical applications.

According to the Baltimore-based company, its first clinical application of the technology will be for SARS-CoV-2.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Nov
10
Featured Webinar

IVDR in Light of the COVID Pandemic: The Near Future of In Vitro Diagnostic Testing

Sponsored by
LGC

The COVID-19 pandemic created a paradigm shift in modern healthcare, where regulations, protocols, and mindsets had to be reworked in just a matter of months to keep up with the pace of the virus.

What's Popular?

In Infectious Disease

  1. Danaher Q3 Revenues Up 35 Percent

  2. COVID-19 Testing Plays Into Abbott's Long-Term Diagnostic Strategy

    Premium

  3. Mass Spec Struggles to Demonstrate Utility as Platform for SARS-CoV-2 Dx

    Premium

  4. BioMérieux Q3 Revenues Increase 21 Percent

  5. Eurofins Q3 Revenues Rise 17 Percent on COVID-19 Testing

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.